The National Institute for Health and Care Research (NIHR) Delivery Network plays a vital role in advancing research across the NHS, including primary care settings. Click here to find out more.

The James Lind Alliance is a non-profit making initative that brings together patients and clinicians to identify and establish key research priorities, particularly in the area of cardiovascular disease. Full details can be found on there website here. 

These are several key publications that highlight the need to increase the number of clinical academics, particularly within primary care. Take a look at the below: 

• The Academy of Medical Science - Building clinical academic capacity and the allocation of resources across academic specialties
• Medical Research Council - Clinical researchers in the UK: reversing the decline

The NIHR Research Support Service (RSS) is dedicated to helping researchers design impactful studies and apply for funding to bring their projects to life. Their website provides support on how to develop applications for national, peer-reviewed research programmes. For further information, please click here. 

Key funders supporting cardiovascular research include the National Institute for Health and Care Research and the British Heart Foundation. Full details about what they fund can be found on their website. 

The NIHR Academy offers funding opportunities to support primary care team members across disciplines to conduct essential research. It also provides training and support to health and care researchers at all stages of their careers. 

The aim is to identify key barriers faced by NHS primary care professionals in diagnosing heart failure and referring patients for device therapy such as implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT). Your insights will help improve pathways and patient outcomes. 

This should take approximately 5 minutes to complete. 

Please complete here

This survey has been funded and supported by Medtronic.

The BCS Working Party for Ischaemic Heart Disease (IHD) would hugely appreciate responses to a survey of Prescriber Preferences for Clopidogrel or Aspirin Monotherapy. This brief survey explores the preferences for clopidogrel or aspirin monotherapy for long-term secondary prevention of cardiovascular events and the feasibility of a clinical trial.

If you would be happy to take part, please see further info and link to the survey: A Survey of Prescriber Preferences for Clopidogrel or Aspirin Monotherapy

It should only take a couple of minutes to complete and your input would be appreciated.